New hope for Tough-to-Treat ovarian cancer
Disease control
Terminated
This study tested whether combining two immunotherapy drugs (SON-1010 and atezolizumab) could help control advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The trial involved 40 patients with advanced solid tumors, including those with platin…
Phase: PHASE1, PHASE2 • Sponsor: Sonnet BioTherapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC